Dudediligence.

Indivior Pharmaceuticals, Inc

INDVNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$6,560,974

4 notices · 194,909 sh

Oct 2025 to Oct 2026

Reported ·

$2,064,583

2 sales · 8 buys · $203,601 bought

Oct 2025 to Jun 2026

The two figures cover different periods.

All 2 reported sales carry the 10b5-1 box. Together they are 0.05% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-07-10: Heidbreder Christian, Form 1442026-06-11: Heidbreder Christian, Form 1442026-06-08: Preblick Ryan, Form 1442025-11-07: Cetani Cynthia C, Form 1442026-01-05: NINIVAGGI DANIEL A, bought2026-01-05: Stejbach Mark, bought2026-01-05: Wheadon David E., bought2026-01-05: Ryan Barbara, bought2026-01-05: Humphreys Keith, bought2026-03-06: Kingsley Stuart A, bought2026-03-09: Ryan Barbara, bought2026-03-13: Ryan Barbara, bought2026-06-08: Preblick Ryan, sold2026-06-11: Heidbreder Christian, sold
under a no plan named▼ sale▲ buysize is dollars

Form 144 notices, newest first

2026-07-10Heidbreder Christian, Chief Scientific Officer$764,628
18,586 shplan 2026-03-13Form 4s on file end Jun 23144 ↗
2026-06-11Heidbreder Christian, Chief Scientific Officer$707,383
18,586 shplan 2026-03-13144 ↗
Form 4, 2026-06-12: sold 18,586 at $38.06 Form 4 ↗
2026-06-08Preblick Ryan, Chief Financial Officer$1,357,200
36,000 shplan 2026-03-06144 ↗
Form 4, 2026-06-10: sold 36,000 at $37.70 Form 4 ↗
2025-11-07Cetani Cynthia C, Officer$3,731,763
121,737 shno plan dateno Form 4 on file144 ↗